Journal Article Summary

The article investigates the effectiveness of Shenxiang Suhe Pill (SXSHP), a traditional Chinese medicine, in treating posterior circulation ischemic (PCI) vertigo. This condition is significant as it can lead to debilitating symptoms such as dizziness, which affects daily functioning and quality of life. Understanding alternative treatment options like SXSHP is important, especially for patients who may not respond well to conventional therapies.

In this study, 120 patients diagnosed with PCI vertigo were randomly assigned to three groups: a control group receiving standard Western medicine, a low-dose SXSHP group, and a high-dose SXSHP group. The treatment lasted for 28 days, with assessments made at 14 and 28 days to evaluate symptom improvement, blood flow velocity in the vertebral and basilar arteries, and various blood parameters. The findings indicated that both doses of SXSHP significantly improved symptoms compared to the control group, with the high-dose group showing the most notable benefits in enhancing blood flow and reducing blood viscosity and inflammatory markers.

However, the study has limitations, including a relatively small sample size and a short duration of treatment, which may affect the generalizability of the results. Patients should be cautious and consult healthcare professionals before starting any new treatment, including SXSHP, to ensure it is appropriate for their specific health conditions. It is essential to discuss potential interactions with existing medications and any underlying health issues, particularly concerning liver and kidney function, as the study reported no adverse effects on these organs.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Zhang Yongjian, Xu Lin, Wang Xiaoping, Ma Jianjun, Song Xiaping, Lv Heng, Jin Luyao. The clinical efficacy of Shenxiang Suhe Pill administration in posterior circulation ischemic vertigo: A randomized controlled trial. Medicine 2023. DOI: 10.1097/MD.0000000000036604. PMID: 38134060. PMCID: PMC10735062.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]